Navigation Links
Handling HPV vaccines and screening: The views of 100 authors

Amsterdam, 21 September, 2006 - Elsevier is delighted to announce the publication of a unique supplement to the journal Vaccine: HPV Vaccines and Screening in the Prevention of Cervical Cancer. This special monograph provides a comprehensive and invaluable update for paediatricians, gynaecologists, health educators, policy decision makers, industry and major donor institutions worldwide.

With the arrival of the Human Papillomavirus (HPV) vaccines and the progressive introduction of HPV-based screening technology, the field of cervical cancer prevention is expanding into new areas of influence involving an ever-widening group of professionals. Starting with the offer of HPV vaccines to pre-adolescent girls and the optional vaccination of young and middle-age women, HPV vaccines may in some instances be recommended as a universal vaccine for both genders towards the prevention of cervical cancer. "An unprecedented and phenomenal challenge for Public Health in the 21st century", according to Dr. Xavier Bosch, Guest Editor and driving force behind this monograph; "The background, the results, the challenges and a set of proposals are analyzed by a group of 100 independent experts, leaders in the various relevant fields".

This monograph was officially launched during the 23rd International Papillomavirus Conference & Clinical Workshop in Prague, Czech Republic at the beginning of September 2006. The full version is available at the Vaccine website (http://www.elsevier.com/locate/vaccine). Furthermore, this landmark publication will be available via the HINARI programme, the public-private initiative (launched by the World Health Organization) to bridge the digital divide in health information access (http://www.who.int/hinari/en/).


'"/>

Source:Elsevier


Page: 1

Related biology news :

1. Live vaccines more effective against horse herpes virus
2. Designing vaccines by computer
3. Improving the potential of cancer vaccines
4. Report focuses on challenges to unlocking future promise of vaccines
5. Medical experts: US unlikely to have enough vaccines to stop avian flu
6. Plant-derived vaccines safeguard against deadly plague
7. High-dose flu vaccines appear to safely boost immunity in elderly
8. Protecting virus offers instant flu protection and converts flu infections into their own vaccines
9. Super enzyme may lead way to better tumor vaccines
10. Cellulose nanocrystal research could lead to new vaccines, computer inks
11. Cancer vaccines -- Taking a jab at cancer by stimulating the immune system

Post Your Comments:
(Date:11/4/2009)... N.J., Oct. 20 Quest Dia...eading provider of diagnostic testing, information...r ended September 30, 2009, income from continuing...uted share, from $160 million, or $0.81 per dilute...hird quarter results were reduced by a $0.03 per s...
(Date:11/4/2009)... Mass., Oct. 20 Aware, I...and technology and biometrics software, today repo...d September 30, 2009. ,, Michael Tzannes, Awa...Earlier today, we announced an agreement to sell o..., a new fabless semiconductor company being spun o...
(Date:11/4/2009)..., Calif., Oct. 23 GenVault Corpora...management for genomic discovery, medicine and ide....D., GenVault,s President and CEO, will be present... on October 26th and 27th in La Jolla, CA. ,, D... overview of the company together with recent cust...
Breaking Biology News(10 mins):Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2CSC Announces Agreement to Provide Billing Service to Littleton Internal Medicine Associates 51724 1Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 1Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 2Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 3Aurora Health Care Sponsors Education Event to Improve Care for the Elderly 51719 4United Physicians Goes Green Effective August 1st 2009 51715 1United Physicians Goes Green Effective August 1st 2009 51715 2
...rain forest peoples in Latin America are preparing...al decision-making on climate issues. A major land...s of the UN Framework Convention on Climate Change... when forest leaders from 13 countries and experts...ange and the Peoples of the Forest: Advancing in t...
...have known for centuries: eyes really are windows ...y published in the April 2008 print issue of The F...researchers describe the development of gene probe...to monitor and detect tissue repair in the brain o...lve a risky, invasive, and relatively slow process...
...iewed in the streets of Edinburgh are unaware of o... the eradication of smallpox from the world over ...General Microbiology (SGM), in conjunction with th...vealed that 87% of 200 individuals questioned did ...w extinct. , But theres good news too. The study,...
Other Biology News:International workshop to address capacity building for rainforest leaders 2International workshop to address capacity building for rainforest leaders 3Harvard researchers publish MRI images of genes in action in the living brain 2Most people believe smallpox not an extinct disease 2
(Date:11/5/2009)...re-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) tod...uarter ended September 30, 2009. GenVec reported a...e three months ended September 30, 2009 compared t...the comparable quarter of 2008. For the nine month...$14.1 million ($0.15 per share), compared to a net...
(Date:11/5/2009)...er 5, 2009 at 4:30 p.m. Eastern Time , BOTHEL...- OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or ...udited financial results for the third quarter and... the Company,s highlights for the third quarter of...flect the operations of OncoGenex Technologies Inc...
(Date:11/5/2009)...Newswire-FirstCall/ -- Senomyx, Inc. (Nasdaq: SNM...receptor-based technologies to discover novel flav...ent supply industries, today provided a corporate ...d quarter ended September 30, 2009. Revenues were...red to $4.0 million for the third quarter of 2008,...
(Date:11/5/2009)...nd vision correction experts listed in the Trusted...t the recently concluded American Academy of Ophth...o, California. Dr. Stephen Brint, MD, Dr. Frederic...Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr. Jam...rd Manche, MD, and Dr. Parag Majmudar, MD, all lea...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
... Scientific Group,Inc. (OTC Bulletin Board: BMSN) ...ewly created positions on its management team. Fen... and development company as Laboratory/Scientific,...Assurance Director. , "Dr. Feng Lin and Marily...trative operations of BMSN,s laboratories to ensur...
...- ImmunoVaccine Technologies Inc. (IVT), a vaccine...greement with the National Institute of Allergy an...itutes of Health (NIH), in Maryland, USA. The rese...gens in DepoVax(TM), IVT,s vaccine enhancement sys...malaria. , "NIAID is a world leader in the study o...
...ta Support Picoplatin in Combination with Docetaxe...Castration-Resistant Prostate Cancer - , , - Resu...nical Oncology,s 2009 Genitourinary Cancers Sympos...oniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a ...cology therapies, today announced the presentation...
Other Biology Technology:Bio-Matrix Scientific Group Announces New Hires to Management Team 2ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria 2Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 2Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 3Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 4Poniard Pharmaceuticals Announces New Efficacy and Safety Data from a Phase 2 Picoplatin Trial in Patients with Prostate Cancer 5
Chicken Anti-PSMD1 Polyclonal Antibody, Unconjugated from ProSci, Inc
Terrific Broth from GE Healthcare, formerly Amersham Biosciences
...ole 1200L sets the new standard for value in today...latest technologies and providing tailored solutio... The Atmospheric Pressure Ionization (API) interf...de superior selectivity and sensitivity for pharma...
Mouse Anti-Human beta IG-H3 Monoclonal Antibody, Unconjugated, Clone 348506 from R&D Systems
Biology Products: